GSK Plc (GSK)
50.61
+0.36
(+0.72%)
USD |
NYSE |
Sep 01, 12:00
GSK Cash from Operations (TTM) : 10.64B for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.64B |
| March 31, 2026 | 9.723B |
| December 31, 2025 | 9.661B |
| September 30, 2025 | 9.752B |
| June 30, 2025 | 9.444B |
| March 31, 2025 | 8.090B |
| December 31, 2024 | 7.859B |
| September 30, 2024 | 8.643B |
| June 30, 2024 | 8.700B |
| March 31, 2024 | 8.928B |
| December 31, 2023 | 7.853B |
| September 30, 2023 | 5.984B |
| June 30, 2023 | 4.651B |
| March 31, 2023 | 4.897B |
| December 31, 2022 | 8.091B |
| September 30, 2022 | 11.04B |
| June 30, 2022 | 13.10B |
| March 31, 2022 | 12.87B |
| December 31, 2021 | 9.893B |
| September 30, 2021 | 9.817B |
| June 30, 2021 | 7.346B |
| March 31, 2021 | 8.984B |
| December 31, 2020 | 9.799B |
| September 30, 2020 | 9.044B |
| June 30, 2020 | 11.12B |
| Date | Value |
|---|---|
| March 31, 2020 | 9.528B |
| December 31, 2019 | 9.118B |
| September 30, 2019 | 10.36B |
| June 30, 2019 | 9.878B |
| March 31, 2019 | 10.02B |
| December 31, 2018 | 10.42B |
| September 30, 2018 | 8.567B |
| June 30, 2018 | 8.382B |
| March 31, 2018 | 7.782B |
| December 31, 2017 | 7.970B |
| September 30, 2017 | 8.193B |
| June 30, 2017 | 8.114B |
| March 31, 2017 | 8.622B |
| December 31, 2016 | 7.906B |
| September 30, 2016 | 6.275B |
| June 30, 2016 | 4.561B |
| March 31, 2016 | 3.060B |
| December 31, 2015 | 2.932B |
| September 30, 2015 | 4.238B |
| June 30, 2015 | 5.604B |
| March 31, 2015 | 6.576B |
| December 31, 2014 | 7.508B |
| September 30, 2014 | 7.517B |
| June 30, 2014 | 8.546B |
| March 31, 2014 | 9.802B |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| AstraZeneca PLC | 14.54B |
| Eli Lilly & Co. | 28.08B |
| Merck & Co., Inc. | 19.97B |
| Pfizer Inc. | 13.40B |
| Sanofi | 14.07B |